Once again, the pattern of CVS trading down near daily against WAG and major healthcare players excepting on significant posditive news (i.e., CVS runs slightly UNDER market following "strong news" rather than WAG and sector that can actually with above and above market and counter-market) CONTINUES. CNBC/FF tools show CVS ratio of undermarket performances in positive market but well above average but very strong on market downsides. The buy back was a great tool against this pattern of trading. To break out, CVS not only will need a strong news trend but an even stronger market. However, CVS' pattern of low volitility is as others have reported, "a nice safe haven." I sww many concerns for any type of growth as "selling season" approaches due to the MHS/ESRX merger and the latters resiliency vis a vie margin pressure. The retail side should now become "the strongest part" until there is a clear expression of market reaction to the ESRX/MHS selling season issue. In all, I see no way that CVS has the strength to break resistence at $48-49 but it would take a major market selloff or loss of a major contract before there is market jitters pointing to under $44. SHORT TERM: HOLD (or move into ESRX and WAG as well). LT (ditto). Happy New Year, craig